Back to today’s briefing

Story perspectives

Trump Administration Halts Medicare Access to Anti-Obesity Drugs

4/6/2025

27 5

Summary

Story summary

The Trump administration has put the brakes on a Biden-era plan to broaden access to anti-obesity drugs for over 7 million Medicare and Medicaid recipients. Citing financial worries, the Centers for Medicare and Medicaid Services have left many beneficiaries grappling with steep out-of-pocket expenses, even as obesity rates continue to climb among those in need.

1 of 1

Story summary

The Trump administration has put the brakes on a Biden-era plan to broaden access to anti-obesity drugs for over 7 million Medicare and Medicaid recipients. Citing financial worries, the Centers for Medicare and Medicaid Services have left many beneficiaries grappling with steep out-of-pocket expenses, even as obesity rates continue to climb among those in need.